IRIDEX Corporation (IRIX) vs Lantern Pharma Inc. (LTRN)
A side-by-side comparison of IRIDEX Corporation and Lantern Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IRIX
IRIDEX Corporation
$0.72HealthcareDelayed quote: Oct 6, 2026, 10:23 AM EDT
LTRN
Lantern Pharma Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 10:30 AM EDT
Total return — IRIX vs LTRN
growth of $100 · dividends reinvested · last 6yIRIX -73.3% (-19.7%/yr)LTRN -93.7% (-36.9%/yr)IRIX compounded faster over this window
IRIX LTRN
IRIX vs LTRN: by the numbers
- •IRIX is the larger company ($12M vs $12M market cap).
- •Both run net losses; LTRN's is the smaller (0.00% vs -6.88% net margin).
Metrics side by side
Valuation
| Metric | IRIX | LTRN |
|---|---|---|
| P/S ratio | 0.24 | N/A |
Profitability
| Metric | IRIX | LTRN |
|---|---|---|
| Gross margin | 36.23% | 0.00% |
| Operating margin | -5.39% | 0.00% |
| Net margin | -6.88% | 0.00% |
| ROE | -97.47% | N/A |
| ROIC | -19.53% | -358.04% |
Growth (annualized)
| Metric | IRIX | LTRN |
|---|---|---|
| Revenue CAGR (5Y) | -0.57% | N/A |
| Total return CAGR (5Y) | -38.13% | -37.05% |
Frequently asked
- How have IRIX and LTRN total returns compared?
- Over the past 5 years, IRIX delivered -38.13% and LTRN delivered -37.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.